Novavax Stock Soared 24% After Revenue Jumped 67% and the Vaccine Maker Turned Profitable for the First Time in Three Years
Novavax shares surged 24% after Q4 revenue jumped 67% to $147M, the company posted its first profit in three years, and a Pfizer partnership opened a new growth chapter.